Yang D, Liu M, Jiang J, Luo Y, Wang Y, Chen H, Li D, Wang D, Yang Z, Chen H. Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung Adenocarcinoma. Cancers (Basel) 2022;14. [PMID: 36551704 DOI: 10.3390/cancers14246220][Reference Citation Analysis]
2
Yao S, Deng M, Du X, Chen Q, Huang R, Song J. Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma. Journal of Immunology Research 2022;2022:1-12. [DOI: 10.1155/2022/2181525][Reference Citation Analysis]
3
Loren P, Saavedra N, Saavedra K, De Godoy Torso N, Visacri MB, Moriel P, Salazar LA. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. Front Pharmacol 2022;13:831099. [PMID: 35444536 DOI: 10.3389/fphar.2022.831099][Reference Citation Analysis]